Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Enterprise Value (2020 - 2026)

BioScience Health Innovations has reported Enterprise Value over the past 7 years, most recently at -$1.1 million for Q1 2026.

  • Quarterly Enterprise Value fell 11.34% to -$1.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.1 million through Mar 2026, down 11.34% year-over-year, with the annual reading at -$661925.0 for FY2025, 0.09% changed from the prior year.
  • Enterprise Value was -$1.1 million for Q1 2026 at BioScience Health Innovations, down from -$661925.0 in the prior quarter.
  • Over five years, Enterprise Value peaked at -$9464.0 in Q1 2023 and troughed at -$1.3 million in Q2 2025.
  • The 5-year median for Enterprise Value is -$92935.0 (2024), against an average of -$396933.1.
  • The largest YoY upside for Enterprise Value was 70.52% in 2022 against a maximum downside of 6439.04% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$28343.0 in 2022, then skyrocketed by 32.12% to -$19238.0 in 2023, then tumbled by 3343.79% to -$662517.0 in 2024, then grew by 0.09% to -$661925.0 in 2025, then tumbled by 72.98% to -$1.1 million in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Enterprise Value are -$1.1 million (Q1 2026), -$661925.0 (Q4 2025), and -$1.1 million (Q3 2025).